Critical Digestion
Natural health product licensed in Canada
- Licence holder
- Enzyme Science
- NPN or DIN-HM
- 80041984
- Status
- Active licence
- Licence date
- 26 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Beta-fructofuranosidase Source : En entier | 535 FCC SU | Not calculated |
| Beta-fructofuranosidase Source : En entier | 3 mg | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces spp. | 535 FCC SU | Not calculated |
| Beta-fructofuranosidase Source : Saccharomyces spp. | 3 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,500 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 15 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 1,500 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 15 mg | Not calculated |
| Hemicellulase Source : Aspergillus niger - En entier | 50 FCC HCU | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,000 XU | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 2,516 FCC PC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 8 mg | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 13.9 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : ATCC SD5275 | 13.9 Millions d'UFC | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 50 Unité de glucoamylase du FCC | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 50 mg | Not calculated |
| Lactobacillus salivarius Source : Cellule entière | 13.9 Millions d'UFC | Not calculated |
| Lactobacillus salivarius Source : ATCC 11742 | 13.9 Millions d'UFC | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 23 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 23 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, triglycérides à chaînes moyennes, Citrate de magnésium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides live microorganisms that temporarily modify gut flora. Alpha-galactosidase helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Protease is a digestive aid. Digestive enzymes. Protease helps digest proteins. Probiotics that temporarily modify gut flora. Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80041984
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.